Medical devices based on hyaluronic acid are constantly being improved. We strive to bring our technical expertise and make your hyaluronic-acid-based medical devices safer and more effective.
We seek to capitalize on our expertise in hyaluronic acid and our raw materials of high quality and purity. So when your formulas are combined with our proprietary manufacturing technology, we add value to the development and implementation of your products.
In collaboration with its partners, SyrHA wishes to contribute to the marketing of innovative products for uses as diverse as aesthetic, ophthalmological and musculoskeletal.
We pride ourselves on our teamwork, transparency, dedication to Swiss quality standards, open-mindedness, efficiency, entrepreneurial spirit and strong customer service.
2000Développement de juvederm
2011Belotero certifié FDA
2013Développement de synolis
2018SyrHatech démarre ses activités de CDMO
2019Développement de INTEXHYA
2020Syrha GMP / ISO 13485 en tant que CDMO